COMP <GO>
AXGN vs CNMD // NET PROFIT MARGIN
Axogen Inc. (NASDAQ) VS. CONMED Corporation (NYSE) • 15-METRIC TALLY: AXGN 6
— CNMD 6
▲ NET PROFIT MARGIN LEADER: CNMD
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
net-margins
-7.00%
LAST: $45.72 (-0.09%) • MKT CAP: $1.36B
net-margins
3.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AXGN VS. CNMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AXGN | CNMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.30% | 54.60% | +19.70 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.60% | 7.80% | -10.40 | CNMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 11.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.10% | 11.07% | -11.17 | CNMD | /fcf-yield <GO> |
| Operating Margin | -3.50% | 7.50% | -11.00 | CNMD | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -7.00% | 3.40% | -10.40 | CNMD | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 5.20% | +15.00 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.82% | -1.82 | CNMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.64 | 1.91 | +16.73 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CNMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.3 | 47.1 | +27.20 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 26.9x | -8.90 | AXGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.96B | $1.36B | $1.60B | AXGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AXGN REV | CNMD REV | AXGN GROSS % | CNMD GROSS % | AXGN FCF | CNMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $225.2M | $1.37B | 74.3% | 54.6% | -$2.9M | $150.9M |
| FY 2024 | $187.3M | $1.31B | 75.8% | 56.1% | $1.4M | $153.9M |
| FY 2023 | $159.0M | $1.24B | — | — | -$12.9M | $125.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AXGN // BETA 1.10
CNMD // BETA —